Local News Indigenous Health Equity Focus of Pathways SymposiumFred Hutch | May 27, 2022It was a coming together of cultures — Indigenous scholars from the Lakota, the Lummi,…dcorriganMay 27, 2022 Read More
Local News Seagen Announces Positive Topline Results of Pivotal Phase II Clinical Trial of TUKYSA® (tucatinib) in Combination With Trastuzumab in HER2-Positive Metastatic Colorectal CancerSeagen | May 27, 2022Seagen announced positive topline results from the pivotal Phase II MOUNTAINEER clinical trial investigating TUKYSA® (tucatinib)…dcorriganMay 27, 2022 Read More
Local News Longtime UW Science Leader Nora Disis on Gender Inequity, Translational Research, and MoreGeekWire | May 27, 2022Mary “Nora” L. Disis has seen a lot of change in her 30 years at…dcorriganMay 27, 2022 Read More
Local News Umoja Biopharma and Lupagen Announce New Collaboration to Improve Patient Experience and Access to Next-Generation In Vivo Therapeutics for CancerUmoja Biopharma | May 25, 2022Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in…dcorriganMay 25, 2022 Read More
Local News Alpine Immune Sciences Announces FDA Removes Partial Clinical Hold on NEON-2 Clinical Trial of Davoceticept (ALPN-202) in Combination with PembrolizumabAlpine Immune Sciences | May 25, 2022Alpine Immune Sciences, a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer…dcorriganMay 25, 2022 Read More
Local News Test of a New ‘Germline-Targeting’ HIV Vaccine Prepares to LaunchFred Hutch | May 24, 2022Since 2013, Dr. Leo Stamatatos has been developing a different kind of HIV vaccine intended…dcorriganMay 24, 2022 Read More
Local News After Sprint for COVID-19 Vaccines, Researchers Return to HIV Marathon with Fresh Determination and Knowledge, Launch Clinical Research Registry and Ad CampaignFred Hutch | May 20, 2022Building on momentum from the highly successful COVID-19 vaccine clinical trials, the HIV Vaccine Trials Network (HVTN)…dcorriganMay 20, 2022 Read More
Local News Neoleukin Therapeutics Announces First Patient Treated in Combination Arm of Phase I Trial Evaluating NL-201 in Combination with KEYTRUDA (Pembrolizumab)BioSpace | May 19, 2022Neoleukin, a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, announced…dcorriganMay 19, 2022 Read More
Local News Benaroya Research Institute Team Discovers T Cell Based Biomarker and Potential Therapeutic Target for Colon CancerBenaroya Research Institute at Virginia Mason | May 19, 2022Studies in the lab of Steven F. Ziegler, PhD, at Benaroya Research Institute (BRI) found that…dcorriganMay 19, 2022 Read More
Local News Unlocking Biotechnology with RNAUW Molecular Engineering & Sciences Institute | May 19, 2022Imagine if there were drugs that could optimize their dose in real-time, leading to better…dcorriganMay 19, 2022 Read More